文献速递慢性肾脏病

通过乙酰化PPARγ恢复Klotho可减缓慢性肾脏病进展

Klotho restoration via acetylation of Peroxisome Proliferation-Activated Receptor γ reduces the progression of chronic kidney disease.
PubMed 文献 · Kidney Int · 2017-04-14

该研究在腺嘌呤诱导的CKD小鼠模型中探讨PPARγ乙酰化调控肾脏Klotho表达的机制。泛HDAC抑制剂TSA通过增强PPARγ乙酰化(K240和K265位点)上调Klotho并减轻肾损伤,该保护作用在PPARγ敲除小鼠中消失。选择性抑制HDAC3可减轻Klotho丢失和肾损伤,而Klotho敲低后保护作用消失,提示靶向HDAC3-Klotho轴具有治疗潜力。

要点

  • TSA通过增强PPARγ乙酰化上调Klotho并减轻CKD小鼠肾损伤。
  • PPARγ K240和K265乙酰化是调控Klotho转录的关键位点。
  • 选择性抑制HDAC3可减轻Klotho丢失和肾损伤,依赖Klotho。

核心结论

  • HDAC3抑制通过增强PPARγ乙酰化恢复Klotho表达,从而减轻CKD进展。

研究设计与样本

  • 腺嘌呤诱导的CKD小鼠模型,使用泛HDAC抑制剂TSA和选择性HDAC3抑制剂干预。
  • 采用PPARγ敲除小鼠和Klotho siRNA敲低验证机制。

主要发现

  • TSA通过增强PPARγ乙酰化、促进PPARγ与Klotho启动子结合及PPARγ依赖的Klotho转录上调Klotho。
  • PPARγ K240和K265乙酰化对Klotho调控起重要作用。
  • TSA的肾脏保护作用在PPARγ敲除小鼠中消失。
  • 腺嘌呤喂养CKD小鼠肾脏HDAC3上调失调。
  • 选择性HDAC3抑制减轻Klotho丢失和肾损伤,Klotho敲低后保护作用大部分消失。

临床怎么用

  • 靶向HDAC3抑制可能通过恢复Klotho减缓CKD进展,具有治疗潜力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Klotho is an anti-aging protein mainly expressed in the kidney. Reduced Klotho expression closely correlates with the development and progression of chronic kidney disease (CKD). Klotho is also a downstream gene of Peroxisome Proliferation-Activated Receptor γ (PPARγ), a major transcription factor whose functions are significantly affected by post-translational modifications including acetylation. However, whether PPARγ acetylation regulates renal Klotho expression and function in CKD is unknown. Here we test whether renal damage and reduced Klotho expression in the adenine CKD mouse model can be attenuated by the pan histone deacetylase (HDAC) inhibitor trichostatin A. This inhibition up-regulated Klotho mainly through an enhancement of PPARγ acetylation, stimulation of PPARγ binding to Klotho promoter, and PPARγ-dependent increase in Klotho transcription, with a substantial control of the regulation occurring via PPARγ acetylations on K240 and K265. Consistently trichostatin A-induced reversal of Klotho loss and renoprotective effects were abrogated in PPARγ knockout mice, supporting that PPARγ is an essential acetylation target for Klotho restoration and renal protection. Intriguingly, the kidneys of adenine-fed CKD mice displayed deregulated HDAC3 up-regulation. Selective HDAC3 inhibition effectively alleviated Klotho loss and kidney injury, whereas the protective effects were largely abolished when Klotho was knocked down by siRNA, suggesting that aberrant HDAC3 and Klotho loss are crucial components involved in the renal damage of mice with CKD. Our study identified an important signaling cascade and key components contributing to the pathogenesis of CKD. Thus, targeting Klotho loss by HDAC3 inhibition has promising therapeutic potential for the reduction of CKD progression.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Lin W, Zhang Q, Liu L, et al. Klotho restoration via acetylation of Peroxisome Proliferation-Activated Receptor γ reduces the progression of chronic kidney disease. Kidney Int. 2017. PMID: 28416226. doi:10.1016/j.kint.2017.02.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。